NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1174515217 MD
Verify on CMS → Jay Penafiel, MD
Cardiovascular Disease Physician in Glen Burnie, Maryland.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 25,298 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 486 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
62.5/100
▼ 21 pts below national avg 83.5 · Mid-tier
Industry payments
$76.78
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Jay Penafiel, MD reported a CMS MIPS final score of 62.5/100 - below the 83.5 national average - and filed 3,574 Medicare Part D claims in 2024.
- 62.5/100
- MIPS score · -21 vs avg
- 4K
- Part D claims, 2024
- 87%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jay Penafiel, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174515217), first enumerated 08/16/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,574 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 62.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$76.78 in reported industry payments (4 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1174515217 · Cardiovascular Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1174515217
- ENUM-LEGACY 2005
- TAX-MID 25K Cardiovascular Disease
- MIPS-LOW 62.5/100
- RX-MID 3,574
- BOOK-LIGHT 594 in Maryland
- PHOTO-FINISH Hani Douedi · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Hani Douedi · lo…
Hani Douedi
62.4 MIPS pts
- Thomas Rizzo · n…
Thomas Rizzo
62.4 MIPS pts
- Penafiel · this …
Penafiel · this provider
62.5 MIPS pts
- Kenneth Wool · h…
Kenneth Wool
62.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Jay Penafiel, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
63 ≥ 6th percentile 6% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jay Penafiel, MD sits
This provider among cardiovascular disease physician peers
Across the 7,999 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jay Penafiel, MD writes more Part D claims than 60% of them and scores higher on MIPS quality than 7% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Jay Penafiel, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jay Penafiel, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jay Penafiel, MD?
Below national averagePrimary specialty
Cardiovascular Disease Physician
Medicare Part D claims
3,574 13% vs specialty avg
MIPS final score
62.5/100 21 pts vs avg
Specialty distribution in Maryland
How Cardiovascular Disease Physician compares to other specialties among Maryland providers
Medicare quality performance, MIPS
Jay Penafiel, MD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 62.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174515217 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/16/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
62.5152
Final Score
Measured-score avg: 83.5
39.7977
Quality
55.3205
Cost
Reporting: Individual
Hospital and facility affiliations
Facilities where Jay Penafiel, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University OF Maryland Baltimore Washington Heart Associates LLC
Glen Burnie, MD
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jay Penafiel, MD. Source: openpaymentsdata.cms.gov.
Total received
$77
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Jay Penafiel, MD - brand share 13.0%
Cardiovascular Disease Physician average
13% brand-name claims vs 87% generic, on 3,574 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,574
Total Claims
$617K
Total Drug Cost
486
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 9,946.667
- Total Day Supply
- 297,505
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $549K
- Generic Drug Cost
- $68K
Patient Demographics
- Average Patient Age
- 76.1 years
- Avg HCC Risk Score
- 1.42
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 15, 65-74: 198, 75-84: 203, 85+: 70
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jay Penafiel, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Metoprolol Succinate
Metoprolol Succinate
517 claims
- Atorvastatin Calcium
Atorvastatin Calcium
313 claims
- Eliquis
Eliquis
213 claims
- Lisinopril 190
Lisinopril
190 claims
- Clopidogrel 167
Clopidogrel
167 claims
- Furosemide 148
Furosemide
148 claims
- Xarelto 145
Xarelto
145 claims
- Amlodipine Besylate 140
Amlodipine Besylate
140 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 517 |
| Atorvastatin Calcium | 313 |
| Eliquis Apixaban | 213 |
| Lisinopril | 190 |
| Clopidogrel Clopidogrel Bisulfate | 167 |
| Furosemide | 148 |
| Xarelto Rivaroxaban | 145 |
| Amlodipine Besylate | 140 |
| Carvedilol | 137 |
| Metoprolol Tartrate | 134 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Jay Penafiel, MD fits within the Cardiovascular Disease Physician landscape nationally.
25,298
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,149
Avg Claims per Provider
Jay Penafiel, MD's 3,574 claims are above the specialty average of 3,149.
Nationwide Cardiovascular Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Penafiel, both outside Maryland so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (62.5 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Cardiovascular Disease Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as Penafiel.
One of 594 Cardiovascular Disease Physician providers enrolled in Maryland, 5 are shown here.
Dr. Seyed Hossein Aalaei-Andabili
M.D
Baltimore, MD
Dr. Leith Abdulla
M.D.
Olney, MD
Dr. Rasaq Abu
M.D.
Berwyn Heights, MD
Dr. Mohammed Abuzahra
MD
Baltimore, MD
Dr. Stephen Achuff
M.D.
Baltimore, MD
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jay Penafiel, MD's specialty? ▼
Jay Penafiel, MD specializes in Cardiovascular Disease Physician and practices in Glen Burnie, Maryland. Credentials: MD.
How much does Jay Penafiel, MD prescribe under Medicare Part D? ▼
In 2024, Jay Penafiel, MD wrote 3,574 Medicare Part D claims totaling $617K in drug costs for 486 beneficiaries.
What is Jay Penafiel, MD's Medicare quality score? ▼
Jay Penafiel, MD has a CMS MIPS Final Score of 62.5/100 (Quality: 39.8, Cost: 55.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jay Penafiel, MD located? ▼
Jay Penafiel, MD is located at 1417 MADISON PARK DR, Glen Burnie, MD, 21061. Phone: (410) 768-6600.
What is Jay Penafiel, MD's NPI number? ▼
Jay Penafiel, MD's National Provider Identifier (NPI) is 1174515217, issued on 08/16/2005.
Does Jay Penafiel, MD prescribe more brand-name or generic drugs? ▼
Jay Penafiel, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $549K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 25,298 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,149 Medicare Part D claims per year.
What drugs does Jay Penafiel, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Jay Penafiel, MD's most frequently prescribed drugs include Metoprolol Succinate, Atorvastatin Calcium, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jay Penafiel, MD accept Medicare? ▼
Jay Penafiel, MD appears in CMS Medicare data with 3,574 Part D claims and 486 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jay Penafiel, MD's credentials? ▼
Jay Penafiel, MD's NPI is 1174515217 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.